11th European AIDS Conference / EACS
Webcasted Presentation

Search’n Build™
Search presentations by keyword and instantly build your own highlight of the conference!


Efficacy and Safety of Maraviroc (MVC) Plus Optimized Background Therapy (OBT) in Viraemic, Antiretroviral Treatment-Experienced Patients Infected with CCR5-Tropic (R5) HIV-1 in Europe, Australia and North America (MOTIVATE 2): 48-Week Results
Gerd Fatkenheuer, Germany    - Biography
English - 2007-10-25
 
Speaker Disclosure
Advisory boards and lecture grants fees from: Abbott, BI, BMS, GSK, Tibotec, Gilead, Pfizer, Schering, Monogram
  ( 16 slide(s) )